Guardant 360 Testing
This unique test made a biopsy optional. It can detect presence of cancer cells using their identifying gene. Statistics show that in 97% the results of test coincided with the data obtained during a complex biopsy. In average 3.3 mutations were identified for 1 patient. Medical check conducted with the test, helps to identify malignant tumors of various types. In particular, cancer:
- Uterine cervix
This list of cancer types, detected by the test Guardant 360, is not exhaustive, scientists continue collect the data in the course of global clinical trials.
One of the best ways to cure cancer, is to find it as early as possible. Everyone knows that the most aggressive forms of cancer can be cured if detected at a very early stage of development. The main problem is that the disease, in most cases, is developing for a long time without any signs, or hiding behind usual discomforts. Test Guardant 360 allows any person to take the test and find in time if he has malignant cells in the body.
Guardant Health specialists using innovative technologies made a genomic study of cells called “Digital Sequence.” It allows physicians to detect even single molecules with 100% accuracy, as these molecules are involved in tumor genomic changes. These moving cancer cells are able to enter blood even after surgical removal malignancy, and further therapy. Using tests developed by Guardant Health, Israeli experts reveal presence of cancer without painful biopsies.